Skip to main content

Table 1 Laboratory variables during follow-up a

From: Hypoparathyroidism after Roux-en-Y gastric bypass - a challenge for clinical management: a case report

  Total calcium (mg/dl) Phosphorus (mg/dl) 25(OH)D (μg/L) PTH (pg/ml) Drugs used to manage calcium metabolism (dose/day)
Normal ranges 8.4 to 10.2 3.5 to 5.0 30 to 80 10 to 65  
After RYGB and before TT 9.0 4.2 64.4 27.9  
2 months post-TT 5.9b 7.1 Calcium carbonate (7.5g)
Calcitriol (2μg)
3 months post-TT 6.2b 6.8 76.6 7.1 Calcium carbonate
Calcitriol (2μg)
4 months post-TT 6.8b 6.8 16.4 Calcium citrate (12g)
Cholecalciferol (12,000IU)
Calcitriol (2μg)
6 months post-TT 7.2b 5.0 Calcium citrate (12g)
Cholecalciferol (12,000IU)
Calcitriol (2μg)
Pancrelipase (3 capsules/day)
8 months post-TT 7.8b 5.2 67.9 8.0 Calcium citrate (14g)
Cholecalciferol (12,000IU)
Calcitriol (2μg)
Pancrelipase (3 capsules/day)
14 months post-TT, pregnant second trimester 7.1b 5.2 49.2 5.9 Calcium citrate (14g)
Cholecalciferol (12,000IU)
Calcitriol (1.5μg)
Pancrelipase (3 capsules/day)
Last measurements 8.8b 5.1 34.8 Calcium citrate (18g)
Cholecalciferol (12,000IU)
Calcitriol (1.5μg)
Pancrelipase (3 capsules/day)
  1. a25(OH)D, 25-hydroxyvitamin D; PTH, Parathyroid hormone; RYGB, Roux-en-Y gastric bypass; TT, Total thyroidectomy. bTotal calcium was corrected by albumin levels.